CognitiveCare Receives a Grant of Nearly $1 Million to Advance Maternal and Fetal Health

CognitiveCare a Healthcare AI startup and pioneer in maternal and infant health, today announced it has received a $965,871 grant from the Bill & Melinda Gates Foundation to provide antenatal risk stratification AI support for the ARC’s pregnancy surveillance efforts.

According to the World Health Organization (WHO), global maternal mortality is an unacceptably high 810 deaths per day, primarily from preventable or treatable causes. Further, 10–15% of all infants born are preterm and are at increased risk of morbidity and mortality.

As part of this grant, CognitiveCare will detect and quantify propensity for critical adverse outcomes during antepartum, intrapartum, and postpartum stages, by leveraging CognitiveCare’s Maternal Infant Health Insights & Cognitive intelligence ”MIHIC” solution. MIHIC incorporates granular insights and patterns that interplay with clinical and social determinants of health to help detect and quantify risks at individual and population levels. CognitiveCare will first validate its models with local data and will then integrate MIHIC into both the Kenya PRiSMA (western Kenya) and the Aga Khan University & VITAL Pakistan ARC sites’ existing production environments. A segment of this grant is dedicated to train the ARC sites to use MIHIC, ensuring sustainable impact.

“With the foundation’s grant support, our aim is to support caregivers in understanding propensity for risk early enough to help reduce maternal and infant morbidity and mortality,” said Dr. Suresh Attili, Co-Founder and Chief Medical Officer, CognitiveCare. “Decisions on patient care rest with physicians; however, risk scores generated by MIHIC support triaging patients early. The models will further provide explainable AI functionality to help caregivers understand the ‘why’ behind each MIHIC ScoreTM.”

“Given that 94% of all maternal deaths occur in low- and lower-middle-income countries, CognitiveCare is committed to ensuring that low resource settings have access to MIHIC,” said Sheena Gill, President, Americas for CognitiveCare. “With this grant, we take another important step toward our vision to eradicate maternal and infant mortality globally.”

CognitiveCare is working at the forefront of science to build the world’s first comprehensive health risk quantification solution that integrates AI, advanced math, and stats at the intersection of medicine, biology, genomics and social determinants. CognitiveCare’s MIHIC Score™ platform assesses propensity for risk of maternal, fetal and infant health risks categorized as antepartum, intrapartum and postpartum risk scores early in the pregnancy cycle to empower proactive care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Noze states the grant will fund a groundbreaking clinical study aimed at detecting TB in high-burden countries, using the company's DiagNoze® — a handheld breathalyzer designed for the real-time detection and screening of various medical conditions, including infectious diseases such as TB.
Research teams led by a faculty member in Purdue University’s College of Engineering will use two grants from the National Eye Institute totaling $6.7 million to further develop specialized smart soft contact lenses that continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes.
The series B funding round saw participation from venture capital firms Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will deploy the funds towards building further manufacturing capacity and deeper research in the health tracking space notes Ultrahuman.
Bone Health Technologies Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a...
Howard Robin, President and Chief Executive Officer of Nektar Therapeutics: "We are pleased to bring on TCGX as a new high-quality, long-term investor in Nektar as we advance rezpegaldesleukin through our Phase 2b studies in atopic dermatitis and alopecia areata. We are on track to report topline data from these studies in the first half of 2025, which will represent significant inflection points for Nektar. Today's financing further bolsters our financial position and extends the company's cash runway well into the third quarter of 2026."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version